Table 2.
Primary site | HPV+ | HPV− | ||||
---|---|---|---|---|---|---|
K | NK | Hyb | K | NK | Hyb | |
Oral | 0 | 0 | 0 | 35 | 0 | 0 |
Larynx/hypopharynx | 0 | 0 | 1 | 24 | 0 | 1 |
Oropharynx | 0 | 21 | 1 | 6 | 0 | 4 |
K = keratinizing SCC, NK = non-keratinizing SCC, Hyb = hybrid carcinoma
Primary site | HPV+ | HPV− | ||||
---|---|---|---|---|---|---|
K | NK | Hyb | K | NK | Hyb | |
Oral | 0 | 0 | 0 | 35 | 0 | 0 |
Larynx/hypopharynx | 0 | 0 | 1 | 24 | 0 | 1 |
Oropharynx | 0 | 21 | 1 | 6 | 0 | 4 |
K = keratinizing SCC, NK = non-keratinizing SCC, Hyb = hybrid carcinoma